Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $217.46 | 5 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| REVANCE THERAPEUTICS, INC. | $167.45 | 2 | $0 (2024) |
| Galderma Laboratories, L.P. | $27.92 | 2 | $0 (2021) |
| ACADIA Pharmaceuticals Inc | $22.09 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $167.45 | 2 | REVANCE THERAPEUTICS, INC. ($167.45) |
| 2023 | $22.09 | 1 | ACADIA Pharmaceuticals Inc ($22.09) |
| 2021 | $27.92 | 2 | Galderma Laboratories, L.P. ($27.92) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/09/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $119.63 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 04/05/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $47.82 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 06/27/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/04/2021 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $11.31 | General |
| 10/21/2021 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $16.61 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 256 | 518 | $105,165 | $37,829 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 71 | 183 | $32,025 | $12,746 | 39.8% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 100 | 100 | $26,000 | $12,454 | 47.9% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 74 | 221 | $44,200 | $11,160 | 25.2% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 11 | 14 | $2,940 | $1,469 | 50.0% |
About Colton Cranson
Colton Cranson is a Case Management healthcare provider based in Newport, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/04/2020. The National Provider Identifier (NPI) number assigned to this provider is 1235764754.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Colton Cranson has received a total of $217.46 in payments from pharmaceutical and medical device companies, with $167.45 received in 2024. These payments were reported across 5 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($217.46).
As a Medicare-enrolled provider, Cranson has provided services to 256 Medicare beneficiaries, totaling 518 services with total Medicare billing of $37,829. Data is available for 1 year (2023–2023), covering 4 distinct procedure/service records.
Practice Information
- Specialty Case Management
- Location Newport, RI
- Active Since 03/04/2020
- Last Updated 03/04/2020
- Taxonomy Code 163WC0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1235764754
Products in Payments
- DAXXIFY (Drug) $167.45
- NUPLAZID (Drug) $22.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.